(1)
Menter, A. M.; Draelos, Z.; Heim, J.; Gogineni, R.; Griffiths, C. E. Efficacy and Safety by Body Weight Decile in Patients Treated With Tildrakizumab 100 Mg for 28 Weeks: Pooled Data Analysis of ReSURFACE 1 and ReSURFACE 2. J of Skin 2023, 7, s136.